Why observational studies should be among the tools used in comparative effectiveness research

Health Affairs

Volumn 29, Issue 10, 2010, Pages 1818-1825

  Dreyer, Nancy A ^a   Tunis, Sean R ^b   Berger, Marc ^c   Ollendorf, Dan ^d   Mattox, Pattra ^a   Gliklich, Richard ^a  

^a Outcome Sciences   (United States)

^b Center for Medical Technology Policy   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE EFFECTIVENESS; METHODOLOGY; OBSERVATION; UNITED STATES;

COMPARATIVE EFFECTIVENESS RESEARCH; OBSERVATION; UNITED STATES;

EID: 79951684079     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0666     Document Type: Article

References (36)

1. US Department of Health and Human Services, Federal Coordinating Council for Comparative Effectiveness Research. Report to the president and the Congress [Internet]. Washington (DC): HHS; 2009 Jun 30 [cited 2010 Aug 27]. Available from: http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf
2. Patient Protection and Affordable Care Act of 2010, PL 111-148, sec. 6301.
3. Tunis S, Benner J, McClellan M. Comparative effectiveness research: methods development and research infrastructure. Stat Med. 2010; 29(19):1963-76.
4. Tunis SR, Stryker DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-32.
5. Lauer MS, Collins FS. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA. 2010;303:2182-3.
6. Vandenbroucke JP. Observational research, randomized trials and two views of medical science. PLoS Med. 2008;5:0339-43.
7. To access the Technical Appendix, click on the Technical Appendix link in the box to the right of the article online.
8. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: asking the right questions, choosing the right method. Health Aff (Millwood). 2005;24(1):128-32.
9. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008;372:2152-61.
10. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, et al. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009;151(3):206-9.
11. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. N Engl J Med. 2000;342:1069-76.
12. Suissa S. Mortality benefit from unrestricted access to clopidogrel: too good to be true? CMAJ. 2008;178:425-7.
13. Institute of Medicine. Initial national priorities for comparative effectiveness research: report brief [Internet]. Washington (DC): National Academies Press; 2009 Jun [cited 2010 May 12]. Available from: http://www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx
14. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010: 303(23):2359-67.
15. Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD. JAMA. 2010;303(23): 2409-10.
16. Tan H, Sarawate C, Singer J, Elward K, Cohen RI, Smart BA, et al. Impact of asthma controller medications on clinical, economic and patientreported outcomes. Mayo Clin Proc. 2009;84(8):675-84.
17. HealthCore [Internet].Wilmington (DE): HealthCore; c2009. Press release, HealthCore study reports that compliant patients have better results with inhaled corticosteroids; 2009 Aug 26 [cited 2010 Jul 23]. Available from: http://www.drugs.com/clinical_trials/comparativeeffectiveness-research-studymayo-clinic-proceedingsdemonstrated-asthma-patients-had-7960.html
18. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301:1661-70.
19. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, Shaughnessy CO, et al. Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
20. Stone GW, Ellis SG, Cox DA, Hermiller J, Shaughnessy CO, Mann JT, et al. A polymer-based, Paclitaxel- eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.
21. Farb A, Boam AS. Stent thrombosis redux: the FDA perspective. N Engl J Med. 2007;356:984-7.
22. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115:1440-55.
23. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of Sirolimusand Paclitaxel-eluting coronary stents. N Engl J Med. 2007;356: 998-1008.
24. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-9.
25. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, et al. Long-term outcomes with drug-eluting stents versus baremetal stents in Sweden. N Engl J Med. 2007;356(10):1009-19.
26. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morder C. Early and late coronary stent thrombosis of Sirolimus-eluting and Paclitaxeleluting stents in routine clinical practice: data from a large twoinstitutional cohort study. Lancet. 2007;369:667-8.
27. Food and Drug Administration. Update to FDA statement on coronary drug-eluting stents January 4, 2007. MedSun [serial on the Internet]. 2007 Jan 11 [cited 2010 Sep 16]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/medsun/news/printer.cfm?id=575
28. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. Clinical outcomes and stent throm-bosis following off-label use of drugeluting stents. JAMA. 2007;297(18): 2001-9.
29. Dreyer NA, Schneeweiss S, McNeil B, Berger ML, Walker A, Ollendorf DA, et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care. 2010;16:467-71.
30. Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting, and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force report- part I. Value Health. 2009;12: 1044-61.
31. Cox E, Martin BC, Van Staa T, Garbe E, Siebert U, Johnson ML. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary sources: the International Society for Pharmacoeconomics and Outcome Research Good Research Practices for Retrospective Analysis Task Force report-part II. Value Health. 2009;12:1053-61.
32. Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force report-part III. Value Health. 2009;12:1062-72.
33. Dreyer NA. Making observational studies count: shaping the future of comparative effectiveness research. Epidemiology. Forthcoming.
34. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias. JAMA. 2007;297:278-85.
35. Rothman KJ, Evans S. Extra scrutiny for industry funded trials: JAMA's demand for an additional hurdle is unfair-and absurd. BMJ. 2005;330: 1350-1.
36. Popper KK. Conjectures and refutations: the growth of scientific knowledge. New York (NY): Basic Books; 1962.